| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 658719 | 68593 | TOPIRAMATO STADA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO STADA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 100 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68593/68593_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68593/68593_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-03-14 | 1 | 1 | 1 | 2007-03-14 | 2007-03-14 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 658721 | 68594 | TOPIRAMATO STADA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO STADA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 200 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68594/68594_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68594/68594_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-03-14 | 1 | 1 | 1 | 2007-03-14 | 2007-03-14 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 659049 | 68798 | RISPERIDONA STADA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA STADA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68798/68798_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68798/68798_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-16 | 1 | 1 | 1 | 2007-05-16 | 2007-05-16 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 659050 | 68798 | RISPERIDONA STADA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA STADA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 30 ml | 1 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68798/68798_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68798/68798_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-05-16 | 1 | 1 | 1 | 2007-05-16 | 2007-05-16 | 1 | 2011-02-17 | View Edit Delete | ||||||||||||
| 660285 | 69487 | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL STADA 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas (FRASCO) | 40 mg | 6 | 28 | 43 | 28 cápsulas (FRASCO) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69487/69487_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69487/69487_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6220 | LABORATORIO STADA S.L. | 2007-12-21 | 1 | 1 | 1 | 2007-12-21 | 2007-12-21 | 1 | 2012-10-25 | View Edit Delete | ||||||||||||
| 659504 | 69076 | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 30 ml | 1 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69076/69076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69076/69076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-07-09 | 1 | 1 | 1 | 2007-07-09 | 2007-07-09 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 659505 | 69076 | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA NORMON 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69076/69076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69076/69076_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2007-07-09 | 1 | 1 | 1 | 2007-07-09 | 2007-07-09 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 660259 | 99123012 | RENAGEL 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | RENAGEL 800 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 800 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/99123012/99123012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/99123012/99123012_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41749 | SANOFI AVENTIS S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 659144 | 62114 | SICCAFLUID 2,5 mg/g GEL OFTALMICO | SICCAFLUID 2,5 mg/g GEL OFTALMICO , 1 tubo de 10 g | 2,5 mg/g | 6 | 10 | 21 | 1 tubo de 10 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62114/62114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62114/62114_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20729 | LABORATORIOS THEA S.A. | 1998-10-01 | 1 | 1 | 1 | 1998-10-01 | 1998-10-01 | 1 | 2011-05-31 | View Edit Delete | ||||||||||||
| 660248 | 69475 | DICLOABAK 1 mg/ml COLIRIO EN SOLUCION | DICLOABAK 1 mg/ml COLIRIO EN SOLUCION, 1 frasco de 10 ml (PE) | 1 mg/ml | 6 | 10 | 26 | 1 frasco de 10 ml (PE) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69475/69475_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69475/69475_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2007-12-14 | 1 | 1 | 1 | 2007-12-17 | 2007-12-14 | 1 | 2011-10-18 | View Edit Delete | ||||||||||||
| 659856 | 69265 | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 250 ml | 1 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69265/69265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69265/69265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-09-19 | 1 | 1 | 1 | 2007-09-19 | 2007-09-19 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 659610 | 69135 | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos (FRASCO) | 25 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69135/69135_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69135/69135_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659612 | 69136 | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 50 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69136/69136_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69136/69136_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659618 | 69137 | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 100 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69137/69137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69137/69137_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659620 | 69138 | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 200 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69138/69138_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69138/69138_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659767 | 69214 | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL , 1 frasco de 200 ml | 50 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69214/69214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69214/69214_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-08-08 | 1 | 1 | 1 | 2007-08-08 | 2007-08-08 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 658831 | 62133 | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA , 1 frasco de 30 ml | 40 mg/ml + 12 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62133/62133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62133/62133_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 660113 | 03268004 | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 625 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03268004/03268004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03268004/03268004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 658607 | 68535 | PRAVASTATINA QUALIGEN 10 mg COMPRIMIDOS EFG | PRAVASTATINA QUALIGEN 10 mg COMPRIMIDOS EFG , 28 comprimidos | 10 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68535/68535_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68535/68535_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658608 | 68536 | PRAVASTATINA QUALIGEN 20 mg COMPRIMIDOS EFG | PRAVASTATINA QUALIGEN 20 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg | 6 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68536/68536_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68536/68536_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2007-02-27 | 1 | 1 | 1 | 2007-02-27 | 2007-02-27 | 1 | 2012-01-02 | View Edit Delete |
Page 151 of 1034, showing 20 records out of 20674 total, starting on record 3001, ending on 3020